Evaluation of muscle activity patterns in patients with severe obstructive sleep apnea

ISRCTN ISRCTN12596010
DOI https://doi.org/10.1186/ISRCTN12596010
Secondary identifying numbers AWGAP-2021-02
Submission date
20/03/2021
Registration date
24/03/2021
Last edited
27/02/2023
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
Obstructive Sleep Apnoea/Hypopnoea Syndrome (OSAHS) is a condition whereby the upper airways collapse intermittently and repeatedly during sleep. This can vary between an apnoea (no airflow through the airways) and a hypopnoea (a reduction of airflow through the airways).
Deciding the best course of treatment for OSAHS can be difficult without knowing which muscles are not working correctly. A relatively new technique for visually assessing the muscles is called the OMES protocol (Orofacial Myofunctional Evaluation Protocol with Scores).
The aim of this study is to compare the OMES protocol with other available measures of tongue muscle strength.

Who can participate?
Patients diagnosed with sleep apnoea-hypopnoea at the participating hospitals

What does the study involve?
Selection visit: an initial sleep study (with measurement of baseline AHI, night-time oxygen desaturation index and the lowest night-time oxygen saturation figures)
One-off visit: The patient is evaluated by the speech therapist and fills in the sleepiness questionnaires, following which the OMES protocol is applied and the evaluation is carried out with the IOPI (Iowa Oral Performance Instrument) and the digital spoon.

What are the possible benefits and risks of participating?
None

Where is the study run from?
Hospital Quironsalud Marbella (Spain)

When is the study starting and how long is it expected to run for?
March 2021 to September 2022

Who is funding the study?
Investigator initiated and funded

Who is the main contact?
Carlos O'Connor Reina, coconnor@us.es.

Contact information

Dr Carlos O'Connor Reina
Scientific

Avda Menendez y Pelayo 44 5c
Sevilla
41003
Spain

ORCiD logoORCID ID 0000-0002-1670-4235
Phone +34 952774200
Email carlos.oconnor@quironsalud.es

Study information

Study designProspective controlled quasi-experimental pilot study
Primary study designObservational
Secondary study designCase-control study
Study setting(s)Hospital
Study typeDiagnostic
Participant information sheet ISRCTN12596010_PIS.docx
Scientific titleValidation of Orofacial Myofunctional Evaluation Protocol with Scores (OMES) with objective measurement of oropharyngeal muscle tone using Iowa Oral Performance Instrument (IOPI) and tongue digital spoon in severe obstructive sleep apnea hypopnea syndrome (OSAHS)
Study acronymOMESIOPITDS
Study objectivesThe use of the OMES protocol can be complemented by the values obtained through the IOPI instruments and the tongue digital spoon in severe OSAHS patients.
Ethics approval(s)Approved 17/03/2021, The Research Ethics Committee of the Hospital Provincial de Málaga (Regional University Hospital, 7th floor Pabellón A, Avda. –Carlos Haya s / n.
29010-Malaga, Spain; +34 951 29 1447; no email address available), ref: AWGAP-2021-02
Health condition(s) or problem(s) studiedSleep apnoea, severe obstructive sleep apnea-hypopnea syndrome
InterventionA myofunctional evaluation of the patient diagnosed with OSAHS will be conducted in the same week as the polysomnography is performed. During this evaluation, patients are blindly examined by a speech therapist and their examination is recorded on video for later evaluation.

The patient will sit one metre away from the camera with their feet flat on the floor and their back supported by the backrest. The camera (Sony CCD-TRV138 Handycam camcorder: Sony Electronics, San Diego, CA 92127, USA) will be placed on a tripod at face and shoulder height.
The evaluation with the OMES protocol (Annex 4) will then take place, based on the analysis of the following parameters:
1. Appearance/posture
2. Mobility
3. Functions
3.1. Respiration
3.2. Deglutition
3.3. Mastication

As a result of this evaluation with the already validated protocol, the higher the score, the more normal the patient's stomatognathic system.
Subsequently, the muscle tone of the genioglossus muscle and the buccinator muscle are evaluated, taking three measurements of each one and using the highest value.

Finally, the tone of the tongue muscles is measured with the digital spoon, taking three measurements and using the highest one.
The recordings and the data obtained will also be blindly analysed by another examiner.
Intervention typeOther
Primary outcome measureFunction of the stomatognathic musculature of patients measured a single time point using:
1. The OMES protocol (visual inspection)
2. The digital spoon to measure tongue pressure
3. The IOPI (Iowa Oral Performance Instrument) to measure tongue strength and resistance with the genioglossus and buccinator muscle tone
Secondary outcome measuresThere are no secondary outcome measures
Overall study start date18/03/2021
Completion date18/09/2022

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants60
Total final enrolment49
Key inclusion criteriaCurrent inclusion criteria as of 29/03/2021:
Cases:
1. Ages between 18 and 75 years
2. Diagnosis of moderate to severe OSAHS (AHI>30) without having had previous experience of said condition and not undergoing treatment due to different circumstances
3. Not having undergone any previous treatment for OSAHS
4. Signed informed consent (IC) form

Controls:
1. Adequate sleep hygiene
2. No complaints of snoring
3. No complaints of daytime sleepiness
4. Epworth Scale <7 points

Previous inclusion criteria:
Cases:
1. Ages between 18 and 75 years
2. Diagnosis of moderate to severe OSAHS (AHI>15) without having had previous experience of said condition and not undergoing treatment due to different circumstances
3. Not having undergone any previous treatment for OSAHS
4. Signed informed consent (IC) form

Controls:
1. Adequate sleep hygiene
2. No complaints of snoring
3. No complaints of daytime sleepiness
4. Epworth Scale <7 points
Key exclusion criteria1. Cognitive or neurological deficit
2. Inability to answer questionnaires
3. Severe alcoholism
4. Presence of craniofacial malformations
5. Active neoplastic disease
6. History of prior orofacial muscle rehabilitation therapy and any prior apnoea treatment which may modify the study results (surgery, MAD, CPAP)
Date of first enrolment07/04/2021
Date of final enrolment17/09/2022

Locations

Countries of recruitment

  • Spain

Study participating centres

Hospital Quironsalud Marbella
Avda Severo Ochoa 22
Marbella
29603
Spain
Hospital Quironsalud Campo de Gibraltar
Edificio Arttysur. Av de los Empresarios s/n
Palmones Cadiz
11379
Spain

Sponsor information

Hospital Qironsalud Marbella
Hospital/treatment centre

Avda Severo Ochoa 22
Marbella
29603
Spain

Phone +34 972774200
Email investigacion.mlg@quironsalud.es
Website https://www.quironsalud.es

Funders

Funder type

Other

investigator initiated and funded

No information available

Results and Publications

Intention to publish date21/09/2022
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination planWe want to publish results in a high impact peer-reviewed journal.
IPD sharing planThe datasets generated during and/or analysed during the current study will be stored in a non-publically available repository.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Participant information sheet 24/03/2021 No Yes
Protocol file 24/03/2021 No No
Protocol article 01/06/2021 14/06/2021 Yes No
Results article 07/02/2023 27/02/2023 Yes No

Additional files

ISRCTN12596010_PROTOCOL_no_date.docx
uploaded 24/03/2021
ISRCTN12596010_PIS.docx
uploaded 24/03/2021

Editorial Notes

27/02/2023: Publication reference added.
27/09/2022: The total final enrolment was added.
14/06/2021: Publication reference added.
19/04/2021: The ethics approval has been added.
29/03/2021: The following changes were made to the trial record:
1. The recruitment start date was changed from 19/03/2021 to 07/04/2021.
2. The inclusion criteria were updated.
24/03/2021: The following changes were made to the trial record:
1. The participant information sheet was uploaded as an additional file.
2. Uploaded protocol (not peer-reviewed) as an additional file. Version n/a, no date.
23/03/2021: Trial's existence confirmed by The Research Ethics Committee of the Hospital Provincial de Málaga.